Featured Products

AGONIST ANTIBODIES

Checkpoint Agonist Antibody Assays

Detect Agonistic Potential of Antibody Therapeutic Candidates Targeting Checkpoint Receptors

OBESITY/DIABETES ASSAYS

GLP-1, GIP, & GCG Bioassay Kits

MOA-reflective Bioassays to Accelerate Development of Obesity & Diabetes Drugs

HELICASES

Recombinant Helicases Ready-to-assay

Unwinding the Future of DNA, RNA, & Therapeutic Innovation

What's New

Image
EVENTS

Information Regarding Tariff Impact

Image
Image
WEBINARS

Reprogramming Immunity: Designing Smarter Checkpoint Receptor Agonists

Image
Image
APPLICATION NOTES

Functional Cell-based Assay Solutions for Accelerating OBESITY THERAPEUTICS Development: A Study on Tirzepatide

Image
Image
EVENTS

PEGS Conf. May 12-15 Boston, MA. Talk focus: Power of Agonist Antibodies (Immunotherapy & Autoimmunity)

Image
thumbnailImg
EVENTS

Information Regarding Tariff Impact

The current tariff environment is highly volatile, and we understand this is a period of significant uncertainty. While we are diligently assessing the possible impact on our supply chain, Eurofins DiscoverX is committed to ensuring no to minimal disruption in our services.

LEARN MORE

Stay current on our latest innovations, products, and science news in our weekly Drug Discovery and Development Email Newsletter. Subscribe today and tap into our most recent products and assets.

Latest News & Insights